Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent

• US 7,196,183 B2
• Filed: 08/29/2002
• Issued: 03/27/2007
• Est. Priority Date: 08/31/2001
• Status: Active Grant

• Current Assignee: Innogenetics NV (H.U. Group Holdings, Inc.)
• Original Assignee: Innogenetics NV (H.U. Group Holdings, Inc.)
• Inventors: Sablon, Erwin, Quint, Wim, Van Doorn, Leen-Jan
• Primary Examiner(s): Campell; Bruce R.
• Assistant Examiner(s): HORNING, MICHELLE S
• Application Number:
  US10/230,381
• Publication Number:
  US 20030152591A1
• Time in Patent Office: 1,671 Days
• Field of Search: None
• US Class Current: 536/23.1
• CPC Class Codes: C12Q 1/707 non-A, non-B Hepatitis, excluding hepatitis D

Abstract

The present invention relates to genomic nucleotide sequences and amino acid sequences corresponding to the non-coding and coding region of a new type of HCV. The invention relates to new HCV types and subtypes sequences which are different from the known HCV types and subtypes sequences. Particularly, the present invention relates to said new HCV type sequences; a process for preparing them, and their use for diagnosis, prophylaxis and therapy. More particularly, the present invention provides new type-specific sequences of the 5′ NCR, Core, the E1 and the NS5 regions of the new HCV type. These new HCV sequences are useful to diagnose the presence of HCV type genotypes or serotypes in a biological sample. Moreover, the availability of these new type-specific sequences can increase the overall sensitivity of HCV detection and should also prove to be useful for prophylactic and therapeutic purposes.

Claims

1. An isolated HCV polynucleic acid of a clade 6 type 13 HCV genotype, said polynucleic acid characterized in that it is comprising

(i) a 5′

UTR nucleic acid sequence defined by SEQ ID NO;

1, or

(ii) the complement of the nucleic acid sequence of (i);

and wherein said polynucleic acid is RNA, DNA, cDNA or a synthetic polynucleic acid.

9. A recombinant vector comprising a HCV polynucleic acid according to claim 1.

10. The vector according to claim 9 which is an expression vector capable of driving expression of a HCV peptide encoded by the HCV polynucleic acid comprised in said vector.

11. An isolated host cell containing the HCV polynucleic acid according to claim 1 or transformed with a vector containing said HCV polynucleic acid.

12. A method for production of the recombinant polypeptide comprising:

transformation of an appropriate cellular host with a recombinant vector according to claim 9,

culturing said transformed cellular host under conditions enabling the expression of said insert, and,

harvesting said polypeptide.

13. A method for detecting the presence of a HCV virus in a biological sample comprising the step of detecting the presence of a polynucleic acid according to claim 1.

14. The method according to claim 13 comprising the steps of:

(i) obtaining a target HCV polynucleic acid from a biological sample suspected to contain a HCV polynucleic acid or fragment thereof;

(ii) obtaining the nucleic acid sequence of the target HCV polynucleic acid of (i);

(iii) infering, from the nucleic acid sequence obtained in (ii), the presence of a HCV polynucleic acid or fragment thereof and, therefrom, the presence of a HCV virus in said biological sample.

15. The method according to claim 13 comprising the steps of:

(i) obtaining a target HCV polynucleic acid from a biological sample suspected to contain a HCV polynucleic acid or fragment thereof;

(ii) contacting the target HCV polynucleic acid of (i) with an oligonucleotide capable of discriminating at least one genotype-specific nucleotide present in said target HCV polynucleic acid, and said contacting generating a discriminatory signal;

(iii) infering, from the discriminatory signal obtained in (ii), the presence of a HCV polynucleic acid or fragment thereof and, therefrom, the

presence of a HCV virus in said biological sample.

16. A method for determining the genotype of a HCV virus present in a biological sample comprising the step of detecting the presence of a HCV polynucleic acid according to claim 1.

17. The method according to claim 16 comprising the steps of:

(i) obtaining a target HCV polynucleic acid from a biological sample suspected to contain a HCV polynucleic acid or fragment thereof;

(ii) obtaining the nucleic acid sequence of the target HCV polynucleic acid of (i);

(iii) infering, from the nucleic acid sequence obtained in (ii), the presence of a HCV polynucleic acid or fragment thereof and, therefrom, the genotype of said HCV virus present in said biological sample.

18. The method according to claim 16 comprising the steps of:

(i) obtaining a target HCV polynucleic acid from a biological sample suspected to contain a HCV polynucleic acid or fragment thereof;

(ii) contacting the target HCV polynucleic acid of (i) with an oligonucleotide capable of discriminating at least one genotype-specific nucleotide present in said target HCV polynucleic acid, and said contacting generating a discriminatory signal;

(iii) infering, from the discriminatory signal obtained in (ii), the presence of a HCV polynucleic acid or fragment thereof and, therefrom, the genotype of said HCV virus present in said biological sample.

19. The method according to claim 13 which is based on an amplification reaction, a hybridization reaction, a reverse hybridization reaction or a sequencing reaction.

20. The method according to claim 13 comprising:

amplification of the polynucleic acid or fragment thereof with an oligonucleotide;

hybridization of the polynucleic acid or fragment thereof with an oligonucleotide;

or

detection of the polynucleic acid or fragment thereof with an oligonucleotide.

21. The method according to claim 16 comprising determination of the genotype of the polynucleic acid or fragment thereof.

27. A diagnostic kit for determining the presence and/or for determining the genotype of a HCV virus in a biological sample, said kit comprising:

(i) a means for obtaining the nucleic acid sequence of a target HCV polynucleic acid from a biological sample suspected to contain HCV polynucleic acid according to claim 1;

(ii) a means for infering, from the nucleic acid sequence obtained from the target HCV polynucleic acid, the presence of a polynucleic acid sequence unique to a HCV polynucleic acid and, therefrom, the presence in said biological sample of a HCV and/or the genotype of said HCV.

2. An isolated oligonucleotide comprising at least 65 contiguous nucleotides taken from the HCV polynucleic acid defined by SEQ ID NO:

1 or the complement thereof, and comprising, relative to the start codon of the HCV polyprotein coding sequence, an adenine nucleotide at position −

159.

4. The isolated oligonucleotide according to claim 2 which is a primer capable of specifically amplifying a HCV polynucleic acid.

5. The isolated oligonucleotide according to claim 2 which is a probe capable of specifically hybridizing to a HCV polynucleic acid.

6. The isolated oligonucleotide according to claim 2 which is capable of specifically detecting a HCV polynucleic acid.

7. The isolated oligonucleotide according to claim 2 which is capable of determining the genotype of a HCV polynucleic acid.

8. The isolated oligonucleotide according to claim 2 comprising besides deoxyribonucleic acid monomers either one or more of:

a modified nucleotide base,

a labeled nucleotide,

a modified polynucleotide backbone,

a peptide nucleic acid monomer,

a locked nucleic acid monomer, and/or

a ribonucleic acid monomer.

22. A diagnostic kit for detecting the presence of a HCV virus in a biological sample, said kit comprising an oligonucleotide according to claim 4.

23. A diagnostic kit for determining the genotype of a HCV virus present in a biological sample, said kit comprising an oligonucleotide according to claim 4.

24. The diagnostic kit according to claim 22 wherein said oligonucleotide is attached to a solid support.

25. The diagnostic kit according to claim 24 wherein a range of oligonucleotides are attached to specific locations on the solid support.

26. The diagnostic kit according to claim 25 wherein said solid support is a membrane strip and wherein said oligonucleotides are probes coupled to the membrane in the form of parallel lines.

3. An isolated oligonucleotide consisting of at least 65 contiguous nucleotides taken from the HCV polynucleic acid defined by SEQ ID NO:

1 or the complement thereof, and comprising, relative to the start codon of the HCV polyprotein coding sequence, an adenine nucleotide at position −

159.